JPRN-UMIN000050963
Recruiting
未知
Efficacy of biomarkers for predicting relapse in patients with ulcerative colitis with clinical remission: A single-center prospective study - Efficacy of biomarkers for predicting relapse in patients with ulcerative colitis with clinical remission: A single-center prospective study
ational Hospital Organization Kure Medical Center and Chugoku Cancer Center0 sites50 target enrollmentStarted: May 20, 2023Last updated:
Conditionslcerative Colitis
Overview
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- ational Hospital Organization Kure Medical Center and Chugoku Cancer Center
- Enrollment
- 50
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who are hospitalized 2\) Patients with colostomy 3\) Patients who are pregnant or may become pregnant 4\) Patients who smoke 5\) Patients with other inflammatory diseases 6\) Patients receiving the following treatments within 4 weeks (a)NSAIDs (b)Aspirin (c)Budesonide rectal foam and enemas (d)Corticosteroids (e)Cytapheresis 7\) Patients with malignant tumors (except after resection or remission) 8\) Patients judged to be inappropriate for inclusion in this study
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Predictive factor of relapse following clinical remission in ulcerative colitis patients.ulcerative colitisJPRN-UMIN000014731Juntendo University, Faculty of Medicine100
Completed
Not Applicable
A biomarker investigation for the recurrence and/or activity of recurrent glomerulonephritis in renal transplant recipientskidney transplant recipientsJPRN-UMIN000015773Kagawa University, Faculty of Medicine100
Completed
Not Applicable
Clinical Relapse Prediction of Ulcerative Colitis Using an Endoscopy Automated Diagnosis Systemulcerative colitisJPRN-UMIN000036650Digestive Disease Center,Showa University Northern Yokohama Hospital150
Recruiting
Not Applicable
Prospective validation of the prognostic biomarker CD8+ TEMRA cells for disturbed fracture healing.S82.1S82.2S82.3S82.7S82.11S82.18S82.31S72S72.1S72.2S72.3S72.4S72.7S72.8Fracture of upper end of tibiaFracture of shaft of tibiaFracture of lower end of tibiaMultiple fractures of lower legFracture of femurPertrochanteric fractureSubtrochanteric fractureFracture of shaft of femurFracture of lower end of femurMultiple fractures of femurFractures of other parts of femurDRKS00010872Charité Universitätsmedizin Berlin / Berlin-Brandenburger Centrum für Regenerative Therapien / Julius Wolff Institut800
Completed
Not Applicable
Identification of predictive biomarkers for severe progression of COVID-19U07.1COVID-19, virus identifiedDRKS00021591Bundeswehrkrankenhaus Berlin, Klinik I (Innere Medizin)135